You will learn about the new recommendations for treating clotting disorders.
Contact hours available until 9/27/2017.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty, Planners, Authors, and Speakers Conflict of Interest Disclosure:
Planning Committee Member Tammy Mitchell discloses that she holds stock with Hill-Rom.
There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
This educational activity has been co-provided by Anthony J. Jannetti, Inc. and Academy of Medical-Surgical Nurses.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC-COA)
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered nursing, Provider Number, CEP 5387.
1. Discuss the mechanism of action of Coumadin (warfarin) and appropriately determine the target goal of warfarin (Coumadin) for VTE (venothromboembolism) and its other uses, i.e. atrial fibrillation, apical clot, and mechanical valve .
2. Review the new medications in the market, the mechanism of action, side effects, and what to teach our patients.
3. Describe the advantages or disadvantages of the new emerging blood thinners.
4. Outline the guidelines for anticoagulation therapy, e.g. chest guidelines.
9/25/18 1:15 pm